Skip to main content
. 2022 Sep 8;13:969460. doi: 10.3389/fmicb.2022.969460

Table 4.

Evaluation of the benefits of sourdough bread in human health and disease.

Product Dose Model Findings Reference
Two SDB (different fermentation times: 4 h and 24 h) compared with yeast-fermented bread One slice of bread (80 g) at 3-week intervals Clinical trial
(36 healthy volunteers aged 20–31 years)
Double-blind
Highest satiety with SDB fermented for 24 h. In both SDB: faster gastric emptying, lower glycemic responses, higher concentration of total free amino acids and better digestibility Rizzello et al., 2019
SDB (>12 h fermentation) compared with yeast-fermented bread Six slices of the study bread (150 g)/day for 7 days Clinical trial
(26 patients with IBS aged 18–65 years)
Double-blind
Higher reduction in ATIs to their monomeric form
Lower levels of FODMAPs
Laatikainen et al., 2017
Whole-grain rye SDB (40 h of fermentation) compared with yeast-fermented crispbread and unfermented rye crispbread One slice (59.4 g) Clinical trial
(24 healthy adults aged 18–70 years)
Single-blind, cross-over trial
Higher satiety and degradation of β-glucans Zamaratskaia et al., 2017
SDB with low FODMAPs against regular rye SDB 3.5–4 slices (105–120 g) of each bread/day in the 1st week
7–8 slices of SDB (210–240 g) per day from the 2nd to the 4th week
Clinical trial
(87 patients with IBS aged 18–65 years)
Double-blind, placebo-controlled cross-over study
Control of IBS symptoms and reduction of gastrointestinal gas accumulation
Increase in dietary fiber intake and good acceptance
Laatikainen et al., 2016
Whole-grain rye SDB compared with WB and rye-bran-enriched WB 6–10 slices (25–30 g/slice)
In two 4-week test periods
Clinical trial
(21 healthy subjects with mild gastrointestinal symptoms aged 38–65 years); Cross-over study
Lower postprandial insulin concentration
Improvement in the first-phase of insulin secretion
Increase in postprandial concentrations of SCFAs
Lappi et al., 2014
Wholegrain wheat SDB against WB 6 slices (for women) and 7 (for men) of SDB per day (162.5 g)
for 6 weeks
Clinical trial
(14 normoglycemic/normoinsulinemic adults and 14 hyperglycemic/hyperinsulinemic adults aged 43–70 years); Crossover study
Improvement in glucose iAUC in response to an OGTT within hyperglycemic/hyperinsulinemic subjects MacKay et al., 2012
Endosperm rye SDB compared with standard WB One portion (50 g) at intervals of 1–2 weeks In vitro
Starch and protein hydrolysis
Clinical trial
(16 healthy subjects aged 23 ± 3.7 years)
Higher levels of total fiber and phenolic acids and a higher starch hydrolysis rate
Lower postprandial insulin response
Beneficial changes in plasma amino acids and their metabolites
Bondia-Pons et al., 2011
Wholemeal wheat SDB (19.5 h fermentation) compared with WB, wholemeal wheat, and wholemeal wheat + xylanase One slice with crust (50 g) of the test breads Clinical trial
(11 insulin-resistant subjects, aged 40–65 years)
Lowest postprandial glucose and insulin responses Lappi et al., 2010
Two SDB compared with yeast-fermented wholemeal bread and yeast fermented WB One slice (50 g) In vitro
Starch hydrolysis
Clinical trial
(8 healthy volunteers aged 23–25 years)
Significantly lower glycemic responses in SDB
Resistant starch levels were higher in the SDB
Scazzina et al., 2009
Whole wheat SDB (3 h fermentation) compared with whole wheat barley bread and WB One slice (50 g) Clinical trial
(10 overweight male subjects)
Single-blind, cross-over
Lower overall glucose and GLP-1 responses
Lower glucose iAUC
Najjar et al., 2008
SDB (24 h fermentation) with 4 flours compared with yeast-fermented 4-flour bread A portion of 80 g for 2 days Clinical trial
(17 celiac sprue patients)
Double-blind
Intestinal permeability not significantly different from baseline in 13 of the 17 patients Di Cagno et al. (2004)

SDB, Sourdough bread; WB, white bread; IBS, irritable bowel syndrome; ATIs, alpha-amylase/trypsin inhibitors; FODMAPs, Fermentable, Oligo-, Di-, and Mono-saccharides and Polyols; SCFAs, short-chain fatty Acids; OGTT, oral glucose tolerance test; iAUC, incremental area under the curve; GLP-1, glucagon-like peptide 1.